Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
QJM : Monthly Journal of the Association of Physicians|September 8, 2006
Renal amyloidosis in intravenous drug usersJ O Connolly, J D Gillmore, H J Lachmann, et al.Journal of the American College of Surgeons|November 1, 1996
When perfectly HLA-matched kidneys are refused for transplant: implications for a national cooperative sharing systemM D Ellison, T J Breen, D B Davies, et al.Microbial Ecology|November 15, 2013
Aeromonas sobria in chlorinated drinking water suppliesM W Lechevallier, T M Evans, R J Seidler, et al.Clinical Transplants|January 1, 1991
Liver transplantation in the United States: 1988 to 1990S H Belle, K C Beringer, J B Murphy, et al.QJM : Monthly Journal of the Association of Physicians|May 29, 2000
Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English familyJ D Gillmore, D R Booth, M Rela, et al.Journal of Clinical Microbiology|April 1, 1981
Association of Aeromonas sobria with human infectionO P Daily, S W Joseph, J C Coolbaugh, et al.QJM : Monthly Journal of the Association of Physicians|April 29, 2000
The genetic basis of autosomal dominant familial Mediterranean feverD R Booth, J D Gillmore, H J Lachmann, et al.Journal of Internal Medicine|October 13, 2011
Hereditary lysozyme amyloidosis -- phenotypic heterogeneity and the role of solid organ transplantationP T Sattianayagam, S D J Gibbs, D Rowczenio, et al.Abdominal Radiology (New York)|June 2, 2017
Measurement of liver and spleen interstitial volume in patients with systemic amyloid light-chain amyloidosis using equilibrium contrast CTJason Yeung, S Sivarajan, T A Treibel, et al.Transplantation|May 15, 2001
Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26ArgJ D Gillmore, A J Stangou, G A Tennent, et al.Pageof 7